Tiago M. Girao's most recent trade in Immunovant Inc was a trade of 293,505 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Tiago M. Girao | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 293,505 | 293,505 | - | - | Stock Option (Right to Buy) | |
| Immunovant Inc | Tiago M. Girao | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 208,388 | 208,388 (0%) | 0% | 0 | Common Stock | |
| Landos Biopharma Inc | Tiago M. Girao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Landos Biopharma Inc | Tiago M. Girao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Landos Biopharma Inc | Tiago M. Girao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Landos Biopharma Inc | Tiago M. Girao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2021 | 36,000 | 36,000 | - | - | Stock Option (right to buy) |